Effects of glucoraphanin and myrosinase supplementation on glutathione levels in middle-aged adults Other
Conditions
Interventions
This study is a randomized, double-blind, placebo-controlled trial investigating the effects of glucoraphanin and myrosinase supplementation on glutathione levels in middle-aged adults. Participants w
Sponsors
DoNotAge.org
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Aged 40-65 years
Exclusion criteria
Exclusion criteria: 1. Individuals younger than 40 or older than 65 years 2. Current use of glucoraphanin, myrosinase, or sulforaphane-containing supplements 3. Diagnosed metabolic or chronic diseases affecting glutathione levels (e.g., diabetes, liver disease) 4. Use of antioxidant supplements (e.g., NAC, glutathione, vitamin C, or E) within the past 30 days 5. Smoking or excessive alcohol consumption (>14 units per week) 6. Known allergies to cruciferous vegetables or supplement ingredients 7. Participation in another clinical trial within the past 3 months 8. Pregnancy or breastfeeding
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Primary
| Measure | Time frame |
|---|---|
| Glutathione levels measured using blood analysis at baseline (Day 0) and after 30 days of supplementation | — |
Countries
England, United Kingdom
Contacts
Public ContactDoNot Age
Outcome results
None listed